Phathom Pharmaceuticals, Inc. — Director's Dealing 2020

Mar 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2020-03-17

Reporting Person: Stenhouse Mark (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-17	Stock Option (Right to Buy)	$29.84	A	20000	Acquired	2030-03-16	Common Stock (20000)	Direct

Footnotes

F1: The option will vest with respect to one-third of the shares of common stock on March 17, 2021, and will vest with respect to the remaining shares in equal monthly installments over the following two years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.